Cite
HARVARD Citation
Zhang, S. et al. (2018). Towards rational design of RAD51-targeting prodrugs: platinumIV–artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and breast cancer cells. Chemical communications. 54 (83), pp. 11717-11720. [Online].